Bioform Medical Inc last week announced that it has acquired substantially all of the assets of privately held Advanced Cosmetic Intervention Inc (ACI) and associated technology rights for $12 million cash, plus future royalties, and a potential sales-related milestone.
The latter is BioForm Medical’s stated desire to wed ACI’s technology with its Radiesse dermal filler. ACI is the maker of GFX, a "no-tox" device that uses RF energy instead of botulinum toxin to treat wrinkles.
This acquisition is a big deal in our industry. It gives a major provider in aesthetic medicine a commercially available technology for local nerve ablation.